S'abonner

Chernobyl-related ionising radiation exposure and cancer risk: an epidemiological review - 01/09/11

Doi : 10.1016/S1470-2045(02)00727-1 
Kirsten B Moysich, Dr a,  : Assistant Professor, Ravi J Menezes a : Research Associate, Arthur M Michalek b : Professor
a Department of Cancer Prevention, Epidemiology, and Biostatistics, Roswell Park Cancer Institute, Buffalo, NY, USA 
b Dean of Educational Affairs in the Department of Educational Affairs, Roswell Park Cancer Institute, Buffalo, NY, USA 

* Correspondence: Dr Kirsten B Moysich, Department of Cancer Prevention, Epidemiology, and Biostatistics, Roswell Park Cancer Institute, A-320 Carlton House, Elm and Carlton Streets, Buffalo, NY 14226, USA. Tel: +1 716 845 8004. Fax: +1 716 845 8487

Summary

The Chernobyl nuclear accident on 26th April, 1986, led to a massive release of radionuclides into the environment. Although vast areas of Europe were affected by Chernobyl-related ionising radiation, the accident had the greatest impact in Belarus, Ukraine, and the Russian Federation. Epidemiological studies that have investigated the link between the Chernobyl accident and cancer have largely focused on malignant diseases in children, specifically thyroid cancer and leukaemia. There is good evidence to suggest that rates of thyroid cancer in children from the countries that were formally part of the Soviet Union have risen as a consequence of the Chernobyl accident. The findings for childhood leukaemia are less conclusive. Overall rates for this disease do not seem to have been affected by the Chernobyl-related ionising radiation, but there may be a larger risk of infant leukaemia in contaminated areas of Europe. Among adult populations, there is no strong evidence to suggest that risk of thyroid cancer, leukaemia, or other malignant disease has increased as a result of the Chernobyl accident.

Le texte complet de cet article est disponible en PDF.

Plan


© 2002  Elsevier Ltd. Tous droits réservés.© 2002  Courtesy of Joseph Geradts. Publié par Elsevier Masson SAS. Tous droits réservés.© 2002  Courtesy of Maurice Barcos. Publié par Elsevier Masson SAS. Tous droits réservés.
Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 3 - N° 5

P. 269-279 - mai 2002 Retour au numéro
Article précédent Article précédent
  • Mammography screening
  • Nicholas Wilcken
| Article suivant Article suivant
  • Concomitant phyllodes tumour and homolateral breast cancer
  • Leo Auerbach

Déjà abonné à cette revue ?